Medtronic received a report of pipeline flex pushwire separation.The patient was undergoing treatment for an unruptured, saccular aneurysm in the ophthalmic artery (ica.) vessel tortuosity was described as moderate.The devices were prepared as indicated in the ifu.During the procedure, it was reported that the pipeline flex braid was implanted without any reported issues.It was also reported that the pipeline flex pushwire separated at hypotube proximal to wire weld ("from the resheathing pad up"), after the pipeline was deployed.A retrieval device was used to remove the separated segment of the pushwire from the patient.There were no reports of patient symptoms in association with this event.Angiographic results post-procedure were reportedly very good.
|
The device was reported to have been discarded at the site.Since the device was not returned, we are unable to perform further root cause analysis.All devices are 100% tested and all products are 100% inspected for damages and irregularities during manufacture.Updated codes in section 6.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|